Invesaro

Companies ACH 8-K/A

SEC filing · 8-K/A

Accendra Health Inc: Executive or director change

Accendra Health set October 5, 2026 as the start date for incoming CEO Kenneth Gardner-Smith and signed a consulting agreement with outgoing CEO Edward A. Pesicka.

Filed September 28, 2026

Neutral news

What happened

  • Kenneth Gardner-Smith will assume the role of President and Chief Executive Officer on October 5, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Back to Accendra Health Inc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.